Evidence map›Paper›PMID 42071146›Full record

ReviewAdvances in experimental medicine and biology2026

Challenges and Opportunities for Statistics in Omics Data Analysis.

Eunice Carrasquinha, Lisete Sousa, Carina Silva

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eunice CarrasquinhaFaculdade de Ciências, Universidade de Lisboa, Lisbon, Portugal.
Lisete SousaFaculdade de Ciências, Universidade de Lisboa, Lisbon, Portugal. lmsousa@ciencias.ulisboa.pt.
Carina SilvaCEAUL-Centro de Estatística e Aplicações, Universidade de Lisboa, Lisbon, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Omics data, comprising a diverse array of high-throughput molecular datasets, present substantial statistical challenges due to their intrinsic heterogeneity and variability. Effectively distinguishing biologically meaningful variations from random noise requires the application and development of robust statistical approaches. Interdisciplinary collaboration plays a pivotal role in refining these methodologies and enhancing the understanding of intricate biological systems. This chapter reviews the importance of statistical methods in omics data analysis, highlighting the need for ongoing advancements to address key challenges, including experimental design, preprocessing, dimensionality reduction, statistical modeling of complex datasets, and the interpretation of results. The pursuit of improved reliability in biological insights creates opportunities for the development and refinement of advanced statistical methodologies.

Indexed as

Computational BiologyGenomicsAnimalsData Interpretation, StatisticalHumansMachine LearningModels, StatisticalMultiomicsProteomicsResearch DesignExperimental designHigh-dimensional dataMachine learningOmicsStatistics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.